Abstract
Background/Objectives
We postulated that renal replacement therapy (RRT) in ICH patients with advanced chronic kidney disease (CKD) is associated with increased frequency and size of perihematomal edema (PHE) expansion and worse patient outcomes.
Methods
The Get With the Guidelines-Stroke Registry was queried for all patients admitted with ICH (N = 1089). Secondary causes, brainstem ICH, and initial HV < 7 cc were excluded. We identified patients with advanced CKD with and without RRT following admission for ICH. ABC/2 formula was used to measure hematoma volume (HV) and PHE. Patient outcomes were 30-day mortality, 90-day modified Rankin Scale score, and discharge disposition. We used propensity scores and optimal matching to adjust for multiple covariates.
Results
At 48 h post-ICH, PHE expansion was a significant predictor of poor patient outcomes in our cohort. Patients with CKD who received sustained low-efficacy dialysis (SLED) treatment had larger 48 h PHE growth compared to both untreated CKD group (average treatment effect (ATE), 11.5; 95% CI, 4.9–18.1; p < 0.01) and all untreated patients (ATE, 7.43; 95% CI, 4.7–10.2; p < 0.01). Moreover, patients with RRT had significantly worse functional and mortality outcomes.
Conclusions
SLED treatment in ICH patients with CKD was associated with significant increase in rate and frequency of PHE expansion. Absolute increase in PHE during 48-h post-ICH was associated with increased mortality and worse functional outcomes. Further prospective and multicenter evaluation is needed to differentiate the effects of RRT on hematoma dynamics and patient outcomes from those attributed to CKD.
Similar content being viewed by others
Abbreviations
- ICH:
-
Intracerebral hemorrhage
- IVH:
-
Intraventricular hemorrhage
- CKD:
-
Chronic kidney disease
- RRT:
-
Renal replacement therapy
- SLED:
-
Sustained low-efficiency dialysis
- HV:
-
Hematoma volume
- PHE:
-
Perihematomal edema
- mRS:
-
Modified Rankin scale
- ATE:
-
Average treatment effects
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- mGS:
-
Modified Graeb score
- WOC:
-
Withdrawal of care
References
Stats F. National chronic kidney disease fact sheet, 2017. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2017.
Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative. Am J Kidney Dis. 2015;65:403–11.
Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015;386:2145–91.
Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388:1459–544.
Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96:414.
Molshatzki N, Orion D, Tsabari R, et al. Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis. 2011;31:271–7.
An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3.
Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin N Am. 2012;30:771.
Huang BR, Lo YL, Chang CH, Chen TY. Testing the outcome score of spontaneous intracerebral haemorrhage in haemodialysis patients. Intern Med J. 2009;39:692–5.
Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020;91:88–97.
Molnar AO, Bota SE, Garg AX, et al. The risk of major hemorrhage with CKD. J Am Soc Nephrol. 2016;27:2825–32.
Rabiner SF, Molinas F. The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med. 1970;49:346–51.
Di Minno G, Martinez J, McKean M-L, De La Rosa J, Burke JF, Murphy S. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med. 1985;79:552–9.
Remuzzi G, Livio M, Marchiaro G, Mecca GD, De Gaetano G. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron. 1978;22:347–53.
Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical outcomes of intracerebral hemorrhage in hemodialysis patients. World Neurosurg. 2014;81:538–42.
Kumar A, Cage A, Dhar R. Dialysis-induced worsening of cerebral edema in intracranial hemorrhage: a case series and clinical perspective. Neurocrit Care. 2015;22:283–7.
Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke. 2020;22:29.
Urday S, Kimberly WT, Beslow LA, et al. Targeting secondary injury in intracerebral haemorrhage—perihaematomal oedema. Nat Rev Neurol. 2015;11:111.
Grunwald Z, Beslow LA, Urday S, et al. Perihematomal edema expansion rates and patient outcomes in deep and lobar intracerebral hemorrhage. Neurocrit Care. 2017;26:205–12.
Leasure AC, Qureshi AI, Murthy SB, et al. Intensive blood pressure reduction and perihematomal edema expansion in deep intracerebral hemorrhage. Stroke. 2019;50:2016–22.
Eknoyan G, Lameire N, Eckardt K, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:5–14.
Nash DM, Przech S, Wald R, O’Reilly D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017;41:138–44.
Morgan TC, Dawson J, Spengler D, et al. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013;44:635–41.
Volbers B, Staykov D, Wagner I, et al. Semi-automatic volumetric assessment of perihemorrhagic edema with computed tomography. Eur J Neurol. 2011;18:1323–8.
Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–60.
Ducruet AF, Hickman ZL, Zacharia BE, et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery. 2010;66:648–55.
Yang J, Arima H, Wu G, et al. Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies. Stroke. 2015;46:1009–13.
Murthy SB, Moradiya Y, Dawson J, et al. Perihematomal edema and functional outcomes in intracerebral hemorrhage: influence of hematoma volume and location. Stroke. 2015;46:3088–92.
Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke. 2005;36:74–9.
Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38:1072–5.
Yogendrakumar V, Ramsay T, Fergusson DA, et al. Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth. Stroke. 2020;51:1120–7.
Yogendrakumar V, Ramsay T, Fergusson D, et al. New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhage. Neurology. 2019;93:e879–88.
Hansen BM, Morgan TC, Betz JF, et al. Intraventricular extension of supratentorial intracerebral hemorrhage: the modified graeb scale improves outcome prediction in lund stroke register. Neuroepidemiology. 2016;46:43–50.
Tseng H-P, Lin F-J, Chen P-T, et al. Derivation and validation of a discharge disposition predicting model after acute stroke. J Stroke Cerebrovasc Dis. 2015;24:1179–86.
Belagaje SR, Zander K, Thackeray L, Gupta R. Disposition to home or acute rehabilitation is associated with a favorable clinical outcome in the SENTIS trial. J Neurointerv Surg. 2015;7:322–5.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral haemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420.
Kim JK, Shin JJ, Park SK, Hwang YS, Kim TH, Shin HS. Prognostic factors and clinical outcomes of acute intracerebral hemorrhage in patients with chronic kidney disease. J Korean Neurosurg Soc. 2013;54:296.
Jung J-M, Kim HJ, Ahn H, et al. Chronic kidney disease and intravenous thrombolysis in acute stroke: a systematic review and meta-analysis. J Neurol Sci. 2015;358:345–50.
El Husseini N, Kaskar O, Goldstein LB. Chronic kidney disease and stroke. Adv Chronic Kidney Dis. 2014;21:500–8.
Ironside N, Chen C-J, Ding D, Mayer SA, Connolly ES Jr. Perihematomal edema after spontaneous intracerebral hemorrhage. Stroke. 2019;50:1626–33.
Urday S, Beslow LA, Dai F, et al. Rate of peri-hematomal edema expansion predicts outcome after intracerebral hemorrhage. Crit Care Med. 2016;44:790.
Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2015;24:1493–9.
Zang Y, Zhang C, Song Q, et al. Therapeutic effect of early intensive antihypertensive treatment on rebleeding and perihematomal edema in acute intracerebral hemorrhage. J Clin Hypertens. 2019;21:1325–31.
O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200–4.
Sharma S, Waikar SS. Intradialytic hypotension in acute kidney injury requiring renal replacement therapy. In: Seminars in dialysis. Wiley; 2017. p. 553–8.
Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367:2505–14.
Acknowledgements
We thank Caleb Stewart, MD, for assistance with semiautomatic image processing, and Billie Hsieh, MD, for assistance with data collection in the early stages of this study.
Funding
Research reported in this publication is supported by the Ochsner Translational Medicine Research Initiative sponsored by the Ochsner Health (II), and the Ochsner Clinic Foundation (II).
Author information
Authors and Affiliations
Contributions
Alireza Shirazian, MD, MS: Major role in acquisition, statistical analysis & interpretation of the data; drafted the manuscript for intellectual content. Andrés F. Peralta-Cuervo, MD: Major role in the acquisition of data and analysis. Maria P. Aguilera-Pena, MD: Major role in the acquisition of data and analysis. Louis Cannizzaro, MD: Major role in the acquisition of data and analysis. Vi Tran , MD: Major role in the acquisition of data and analysis. Doan Nguyen, PhD: Interpreted the data; revised the manuscript for intellectual content. Ifeanyi Iwuchukwu, MD: Conceptualized and designed the study; interpreted the data and revised the manuscript for intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has anything to disclose.
Ethical approval
The Ochsner Health Institution Review Board approved the use of data obtained from humans in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shirazian, A., Peralta-Cuervo, A.F., Aguilera-Pena, M.P. et al. Sustained Low-Efficiency Dialysis is Associated with Worsening Cerebral Edema and Outcomes in Intracerebral Hemorrhage. Neurocrit Care 35, 221–231 (2021). https://doi.org/10.1007/s12028-020-01155-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-01155-3